Publication Type:

Journal Article


Nature Clinical Practice Neurology, Volume 4, Number 11, p.610-621 (2008)



anticonvulsive agent, benzodiazepine derivative, brain atrophy, Brain Diseases, brain edema, death, disease association, disease course, epileptic state, Febrile, febrile convulsion, high risk patient, hippocampal sclerosis, human, Humans, incidence, morbidity, mortality, nuclear magnetic resonance imaging, prevalence, priority journal, Prognosis, review, risk factor, Seizures, sudden death, systematic review, temporal lobe epilepsy


Approaches to the treatment and investigation of febrile seizures have changed since the main reference studies on outcomes were conducted in the 1960s and 1970s. We have, therefore, conducted a systematic review of literature from the past 15 years to see whether outcomes have also changed. We found that simple febrile seizures do not carry a risk of death, but there is a very small risk of death after complex febrile seizures (CFSs), particularly febrile status epilepticus. There is no evidence that SUDEP (sudden unexpected death in epilepsy) occurs in association with febrile seizures. The risk of later epilepsy after a febrile seizure lies between 2.0% and 7.5%, and the risk of developing epilepsy after CFSs is estimated at around 10-20%. There is no evidence of any risk of hippocampal or mesial temporal sclerosis (HS/MTS) in association with simple febrile seizures. Serial imaging has shown that HS/MTS develops in 0-25% of patients over time after prolonged febrile seizures; the range in prevalence reflects selection bias in different studies. The overall risk of HS/MTS associated with CFSs is around 3%. Approximately 40% of patients with medically refractory temporal lobe epilepsy and HS/MTS on neuroimaging have a history of febrile seizures.


cited By (since 1996)18

Cite this Research Publication

Ma Chungath and Shorvon, Sb, “The mortality and morbidity of febrile seizures”, Nature Clinical Practice Neurology, vol. 4, pp. 610-621, 2008.